Drugs / AL-8309B
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 3 | NCT00890097 | Apr 2009 → May 2012 | age-related macular degeneration, diffuse secondary choroid atrophy | Alcon Research | Terminated | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | AL-8309B | ClinicalTrials.gov intervention name — accepted as the source's own label NCT00890097 ↗ |
| Route | Topical | “administered as a topical ocular drop” NCT00890097 ↗ |